CME/CE Deep Dive into 5: Answering Your Questions on Lipids and Risk

The NACE Clinical Highlights Show

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:
https://www.mycme.com/courses/answering-your-questions-on-lipids-and-risk-9498
Summary
There’s no shortage of information on the management of lipids for the prevention of cardiovascular disease:

• 2018 Guideline on the Management of Blood Cholesterol.
• 2022 ACC Expert Consensus Decision Pathway.
• CLEAR Outcomes, CVOT studies, Risk Calculators.

Helping sort these and other topics out, Dr. James Underberg and Dr. Jessica Pena discuss the top 5 learner submitted questions/topics from the recent programs on non-statin lipid management in primary prevention of ASCVD.
Learning Objectives
Upon completion of this activity, learners should be able to:

• Identify patients at high risk for ASCVD, based on risk factors and testing, who would benefit from additional lipid lowering
• Integrate evolving evidence with guidelines and expert recommendations in the use of non-statin therapies for primary prevention of ASCVD in patients at high risk

This activity is accredited for CME/CE Credit
Association of Black Cardiologists, Inc. (ABC) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Association of Black Cardiologists, Inc. designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and ABC. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.25 contact hours (which includes 0 hours of pharmacology).
For additional information about the accreditation of this program, please contact NACE at [e-mail].
Summary of Individual Disclosures
Please review faculty and planner disclosures here.
Disclosure of Commercial Support
This educational activity is supported in part by an educational grant from Esperion Therapeutics, Inc. and an independent educational grant from Novartis Pharmaceuticals Corporation.

Please visit http://naceonline.com to engage in more live and on demand CME/CE content.